SynOx Therapeutics

Developer of humanized monoclonal antibodies intended to significantly improve the lives of people living with Tenosynovial giant cell tumors (TGCT) and other colony-stimulating factor 1 (CSF-1) and m...

Healthcare

Dublin, Ireland

Founded 2020

11 employees

Website

Valuation

Share Price

N/A

Total Raised

$170.6M

Last Round

N/A

Investors

+6 other investors

View all 6 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock SynOx Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required